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Abstract Seeds of milk thistle, Silybummarianum (L.) Gaertn.,
are used for treatment and prevention of liver disorders and were
identified as a high priority ingredient requiring a validated ana-
lytical method. An AOAC International expert panel reviewed
existing methods and made recommendations concerning meth-
od optimization prior to validation. A series of extraction and
separation studies were undertaken on the selected method for
determining flavonolignans from milk thistle seeds and finished
products to address the review panel recommendations. Once
optimized, a single-laboratory validation study was conducted.
The method was assessed for repeatability, accuracy, selectivity,
LOD, LOQ, analyte stability, and linearity. Flavonolignan con-
tent ranged from 1.40 to 52.86 % in raw materials and dry fin-
ished products and ranged from 36.16 to 1570.7 μg/mL in liquid
tinctures. Repeatability for the individual flavonolignans in raw
materials and finished products ranged from 1.03 to 9.88 %
RSDr, with HorRat values between 0.21 and 1.55. Calibration
curves for all flavonolignan concentrations had correlation coef-
ficients of >99.8 %. The LODs for the flavonolignans ranged
from 0.20 to 0.48 μg/mL at 288 nm. Based on the results of this
single-laboratory validation, this method is suitable for the quan-
titation of the six major flavonolignans in milk thistle raw
materials and finished products, as well asmulticomponent prod-
ucts containing dandelion, schizandra berry, and artichoke ex-
tracts. It is recommended that this method be adopted as First
Action Official Method status by AOAC International.
Keywords Silybummarianum (L.) Gaertn . Flavonolignans .
Silymarins . Dietary supplements . High-performance liquid
chromatography . Validation
Introduction
Herbal dietary supplements, such as milk thistle (Silybum
marianum (L.) Gaertn.), have considerable variation due to
several factors including the quality of starting materials, pro-
cess conditions, product formulations, and storage. Therefore,
stringent analytical methods to evaluate and confirm product
quality for both starting materials and finished products are
necessary. Milk thistle supplements have consistently been
ranked as a top selling product in the past decade and will likely
continue as research accumulates in support of its use as a
hepatoprotectant [1, 2]. The seeds, which are used in herbal
preparations, contain the group of components classified as
the silymarins, which have been shown to have hepatoprotec-
tive, antioxidant, neuroprotective, antidiabetic, and anti-cancer
activities [3–11]. The silymarins are composed of the six major
flavonolignans: silychristin, silydianin, silybin A, silybin B,
isosilybin A, and isosilybin B shown in Fig. 1.
Milk thistle is available in a variety of formulations including
capsules, tablets, tinctures, and dry powders, while other formu-
lations such as phytosomes and liposomes have been developed
to improve flavonolignan bioavailability [12, 13]. Products have
been enhanced by the addition of several other extracts including
schizandra berry, artichoke, and dandelionwhichmay potentially
impact flavonolignan quantitation. Traditionally, flavonolignans
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are determined using HPLC-UV with phosphoric acid in the
mobile phase, which excludes the ability to couple the analyses
for mass spectrometric detection [14–16]. A growing trend for
methods using UPLC and other higher pressure LC systems for
separation of flavonolignans has recently occurred, which re-
duces analysis time and overall solvent usage [17]. As the incor-
poration of such methods would require many herbal product
manufacturers to purchase these new and expensive instruments,
they may not be suitable for ubiquitous product quality analysis
of milk thistle. Another method that manufacturers use to reduce
analysis time is with a non-specific spectrometric method for
quantifying total silymarin content, which may lead to erroneous
values as many components in the extract may absorb at the
specified wavelength.
Clinical evidence of milk thistle efficacy as a hepatoprotectant
and in the treatment of liver damage, disease, and cirrhosis has
been inconclusive [18–23]. Meta-analyses have pointed out sev-
eral flaws in study designs including the lack of chemical char-
acterization of products evaluated and the variable dosages ad-
ministered. To further complicate milk thistle research, clinical
trials refer to milk thistle as silibinin, silymarin, or milk thistle,
which are all separate entities and are not clearly defined between
publications [24]. Inclusion of chemical characterization of prod-
ucts used in milk thistle research is essential in order to evaluate
its effectiveness and may lead to more conclusive findings.
Therefore, it is essential to develop fast, reliable, precise, accu-
rate, and validated methods for individual flavonolignans in milk
thistle raw materials and products.
Milk thistle has been classified as a high priority dietary
supplement requiring a validated method for quantifying
flavonolignan content. In 2009, an AOAC Expert Review
Panel (ERP) convened to evaluate methods submitted for milk
thistle quantitation and determined the INA method 115.00
Silymarins in milk thistle by HPLC was suitable; provided
several modifications are evaluated prior to validation [15,
25]. The ERP recommended several modifications to the orig-
inal method. This method involved defatting of the milk this-
tle seeds for several hours using a Soxhlet extractor, followed
by an overnight methanol Soxhlet extraction of the
flavonolignans [15]. One recommendation of the ERP was
to evaluate the necessity of the defatting step and also to adapt
the method for multiple matrices. Other recommendations in-
cluded evaluating mobile phases compatible with both ultra-
violet and mass spectrometric detectors and improving the
chromatographic separation [25].
The objectives of this work were to address the modifica-
tions suggested by the ERP on milk thistle method optimiza-
tion by using statistically guided optimization procedures.
Several extraction parameters were evaluated including pre-
treatment volume, contact time, and extraction method. The
optimized method for flavonolignans in milk thistle was sub-
jected to a single-laboratory validation according to AOAC
International guidelines [26]. The method quantifies the six
major flavonolignans in several matrixes including raw milk
thistle seeds, bulk extract, single and multi-component cap-
sules, tablets, and tinctures.
Fig. 1 Structure of silychristin
(1), silydianin (2), silybin A (3),
silybin B (4), isosilybin A (5), and
isosilybin B (6)
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Experimental
Reagents and reference materials
HPLC grade methanol was purchased fromVWR Internation-
al (Mississauga, ON, Canada). HPLC grade hexane and ACS
grade formic acid and sulfuric acid were purchased from Fish-
er Scientific (Ottawa, ON, Canada). Water was deionized
using a Barnstead water purification system from Fischer Sci-
entific and further filtered through 0.22 μm nylon filters. The
high-purity certified reference materials silybin A, silybin B,
silychristin, silydianin, isosilybin A, and isosilybin B were
purchased from Cerilliant Corporation (Round Rock, TX). A
silybin A/B combination standard was provided from
Chromadex (Irvine, CA). All standards were stored in a des-
iccator at −20 °C for long-term storage.
Purity assessment of reference materials
To confirm purity, quantitative NMR (qNMR) was performed
on the individual flavonolignan reference standards using a
Varian Mercury VX spectrometer operating at 400.13 MHz
for 1H. Samples were dissolved in deuterated DMSO and
analyzed by standard proton NMR spectrometry for identifi-
cation and qNMR for quantitative analysis according to Pauli
et al. [27]. The silybin A/B mixture standard was assessed for
purity by calibrating the concentrations using the individual
flavonolignan standards.
Test materials
One source of milk thistle seeds was used in the optimization
studies. This source was cultivated in 2009 at Midmore Or-
ganic Farm (Morinville, AB, Canada) and deposited in the
University of Alberta Vascular Plant Herbarium, accession
number ALTA 126811, under the supervision of botanist
Dorothy Fabijan. Eleven samples were used in the single-
laboratory validation. Two sources of S. marianum seeds were
obtained from commercial suppliers. The first being the one
used in the optimization study and the second was purchased
from Horizon Herbs (Williams, OR). A milk thistle powdered
extract was provided by Euromed (Monza, Italy). Several
commercial products were purchased from local health stores.
These include single ingredient milk thistle products and
multi-component products with extracts such as schizandra
berry, dandelion, and artichoke. The test samples are de-
scribed in Table 1.
HPLC analysis
An Agilent 1290 HPLC system equipped with an autosampler,
binary pump, and diode array detector (Agilent Technologies,
Mississauga, ON, Canada) was used. The separation was
achieved on a Kinetex® XB-C18 2.6 μm, 3.0×100 mm column
(Phenomenex, Torrance, CA). The mobile phase was composed
of (a) 0.1 % formic acid in water and (b) 0.1 % formic acid in
80 % aqueous methanol. The flow rate for the separation was
0.4 mL/min (0 to 36 min, 45.1 to 46 min) and 0.45 mL/min
during the re-equilibration (36.1 to 45 min). The gradient elution
was as follows: 0–1 min: 15 %B; 1–2 min: 15–43 %B; 2–
10 min: 43–45 %B; 10–25 min: 45–55 %B; 25–27 min: 55–
60 %B; 27–35 min: 60–100 %B; 35–36 min: 60–100 %B; 36–
36.1 min: 100–15 %B; 36.1–45 min: 15 %B. The column tem-
perature was 25 °C and injection volume was 2 μL. UV spectra
were collected from 200 to 400 nm with 288 nm used for detect-
ing the flavonolignans. Data was processed using OpenLab soft-
ware (Agilent Technologies).
Optimization—pretreatment
Hexane defatting Five 10 g replicates of ground milk thistle
seed were weighed into cellulose extraction thimbles and ex-
tracted with 100 mL of hexane using a Soxhlet apparatus for
6 h. Thimbles were dried at 40 °C to remove residual solvent.
Sulfuric acid pretreatment Five 4 g replicates of ground milk
thistle seed were weighed into 50 mL polypropylene tubes and
treated with 40 mL of 1.5 %v/v sulfuric acid at 50 °C in a water
bath shaker at 60 rpm for 24 h. After cooling to room tempera-
ture, the samples were centrifuged at 5000 rpm for 5 min and the
supernatant was discarded. The solids were recovered and
allowed to dry at room temperature for 24 h.
Five 300 mg replicates of control (no pretreatment), hexane-
treated, and sulfuric acid-treated material were extracted with
40 mL methanol for 30 min using a sonicating bath at 45 °C.
After cooling to room temperature, the samples were centri-
fuged at 5000 rpm for 5 min. The methanol was transferred to
a 50-mL volumetric flask and brought up to volume with
methanol. An aliquot was placed into an HPLC vial and ana-
lyzed for flavonolignan content by HPLC-UV.
Pretreatment contact time Triplicate 200 mg samples of
ground milk thistle seeds were extracted with 10 mL of
1.5 % H2SO4 in a 50 °C water bath shaking at 60 rpm for
0.5, 1, 2, 4, 6, 18, and 24 h. The samples were cooled and
centrifuged at 5000 rpm for 5 min and the supernatant
discarded. Samples were extracted with 25 mL of methanol
and sonicated at 45 °C for 30 min. They were cooled to room
temperature and centrifuged at 5000 rpm for 5 min, and a
1-mL aliquot was analyzed for flavonolignan content by
HPLC-UV.
Pretreatment and rinse volume In triplicate, 200 mg sam-
ples of ground milk thistle seed were pre-treated with either
10 mL 1.5 % H2SO4 solution or 2 mL 1.5 % w/w H2SO4
Optimization and single-laboratory validation 7659
solution for 30 min. Samples were cooled, centrifuged at
5000 rpm for 5 min, and decanted and rinsed by adding either
10 or 2 mL respectively of deionized water. After vortexing
for 30 s, samples were centrifuged at 5000 rpm for 5 min and
the rinse water was discarded. Each sample was extracted with
methanol as per the sonication procedure above and analyzed
for flavonolignan concentration. These experiments were re-
peated with the rinse step omitted.
Optimization—extraction
Soxhlet procedure Five 5 g replicates of defatted groundmilk
thistle seed were extracted with 90 mL of methanol using a
Soxhlet extraction apparatus for 8 h. Extracts were cooled and
transferred to 100 mL volumetric flasks and diluted to volume
with methanol. One milliliter aliquots were analyzed for
flavonolignan concentration. This procedure was repeated
with five 1 g replicates of ground milk thistle tablets.
Sonication procedure Five 150 mg (±10 %) replicates of
defatted ground milk thistle seed were extracted with 25 mL
of methanol using a sonicating bath at 45 °C for 30 min.
Samples were cooled to room temperature and centrifuged at
5000 rpm for 5min, and a sample of the solution was analyzed
for flavonolignan concentration. This was repeated with five
70 mg (±10 %) replicates of ground milk thistle tablets.
Method validation—reference solution preparation
Individual 1000 μg/mL stock solutions of each standard were
prepared by weighing 10 mg of each standard into separate
10mL volumetric flasks and diluted with methanol. Isosilybin
A and isosilybin B stock solutions were diluted to 500 μg/mL
working stock solutions prior to preparation of the calibration
standards each day from the original stock solutions.
The solutions for the calibration curves were prepared
using serial dilutions of the stock solutions with methanol.
The nominal concentrations of each standard in the seven-
point calibration curves are summarized in Table 2.
Method validation—sample preparation
Raw materialsMilk thistle seeds were ground using a water-
jacketed hammer mill or grinder to <40 mesh powder. Test
samples (200.0 mg, ±5.0 mg) were weighed into a 50-mL
conical tube and 2.0 mL of 1.5 % H2SO4 was added. Samples
Table 1 Composition of each
test sample subjected to the
single-laboratory validation
including the dilution required for
the samples to be within the
calibration range of the method
Sample code Sample type Constituents Dilution factor
MT-RM001 Raw material Milk thistle seeds n/d
MT-RM002 Raw material Milk thistle seeds n/d
MT-BE001 Bulk extract Milk thistle extract 1:5
MT-CP001 Hardshell capsule Milk thistle extract 1:10
MT-CP002 Hardshell capsule Milk thistle, schizandra berry 1:10
MT-CP003 Hardshell capsule Milk thistle, dandelion, artichoke extract 1:10
MT-TB001 Tablet Milk thistle extract, milk thistle seed n/d
MT-TB002 Tablet Milk thistle extract 1:10
MT-TN001 Tincture Milk thistle extract 1:5
MT-TN002 Tincture Milk thistle, dandelion extract 1:2
MT-TN003 Tincture Milk thistle extract 1:5
n/d no dilution
Table 2 Nominal concentrations of the individual flavonolignans in each of the calibration solutions
Flavonolignan Approximate concentration (μg/mL) Average correlation
coefficients (r2)
Lin 1 Lin 2 Lin 3 Lin 4 Lin 5 Lin 6 Lin 7
Silychristin 150 100 75 50 15 5 1.5 0.9992
Silydianin 150 100 75 50 15 5 1.5 0.9994
Silybin A 150 100 75 50 15 5 1.5 0.9992
Silybin B 150 100 75 50 15 5 1.5 0.9994
Isosilybin A 75 50 35 20 7.5 2 0.75 0.9993
Isosilybin B 75 50 35 20 7.5 2 0.75 0.9991
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were vortexed for 30 s and placed in a 50 °C shaking water
bath at 60 rpm for 30 min. After the samples were cooled to
room temperature, they were centrifuged at 5000 rpm for
5 min. The pretreatment solution was decanted and 2 mL of
rinse water was added. Samples were vortexed for 30 s and
centrifuged at 5000 rpm for 5 min. The rinse solution was
decanted to waste. Twenty-five milliliters of 100 % methanol
was added to each sample and vortexed for 30 s. The
flavonolignans were extracted for 30 min in a heated sonicat-
ing water bath at 45 °C. Samples were cooled to room tem-
perature and centrifuged at 5000 rpm for 5 min. An aliquot of
the extract was filtered using a 0.45-μm Teflon filter in an
HPLC vial and subjected to HPLC analysis.
Powdered extracts, capsules, and tablets The contents of
the 20 capsules were emptied and combined in a conical tube.
Weights of the contents and empty shells were obtained, and
the average fill weight was recorded. Contents were mixed
using a spatula to homogenize the samples. Twenty tablets/
caplets were combined, weighed, and ground using a coffee
grinder. Test material (100.0 mg, ±5.0 mg) was weighed into a
50-mL conical tube and 25mL of methanol was added using a
volumetric pipet. The samples were vortexed and extracted in
a heated sonicating water bath at 45 °C for 30 min. Samples
were cooled to room temperature and centrifuged at 5000 rpm
for 5 min.
Samples which are outside the calibration range were
diluted either 1:5 or 1:10 with methanol prior to filtra-
tion. The dilution factors for each sample are summa-
rized in Table 1. All samples were filtered using
0.45 μm Teflon filters into HPLC vials and analyzed
by HPLC.
Tinctures Tinctures were mixed thoroughly by inversion and
diluted 1:2 or 1:5 with methanol and vortexed for 30 s. The
dilution factors for each sample are summarized in Table 1.
The diluted samples were filtered using a 0.45-μm Teflon
filter into an HPLC vial and analyzed by HPLC. Note: Dilu-
tion of at least 1:2 is required as the high water content in
tinctures causes solubility issues during filtration.
Method validation
The above method was validated according to AOAC Inter-
national guidelines for conducting single-laboratory valida-
tion [26].
Limits of detection (LOD) and quantitation (LOQ) Suit-
able matrix blank was not available; therefore, the use of the
International Union for Pure and Applied Chemistry method
for determination of detection limits was not possible. The
LOD for each analyte was determined using the US
Environmental Protection Agency Method Detection Limit
(MDL) protocol [28]. The MDL is defined as the minimum
concentration of substance that can be measured and reported
with 99 % confidence that the analyte concentration is greater
than zero. To ensure matrix effects are still present, the tincture
MT-TN003 was diluted so that all flavonolignans were at a
very low concentration. Seven replicates were injected and the
calculation of the MDL was as follows:
MDL ¼ s t 0:01;n−1ð Þ
Where s is the sample standard deviation of the replicates
and t(0.01, n-1) is the t statistic with α=0.01 and n−1 degrees of
freedom.
A second set of seven replicates were assessed by diluting
the tincture to another low concentration. This was performed
to ensure variance is consistent at the low concentrations and
to confirm that the MDLs are valid.
The LOQ was calculated as 10 times the sample standard
deviation of the results for the replicates used to determine the
MDL.
Precision Twelve replicates were analyzed for each test sam-
ple. Four replicate samples of eachmaterial were prepared and
analyzed on three separate days. The within-day, between-
day, and total standard deviation values were calculated for
each of the individual flavonolignans. The HorRat value for
each flavonolignan in each material was also calculated to
assess the overall precision of the method as described by
Horwitz [29].
Accuracy One hundred milligrams of negative control mate-
rial, composed of 99 % maltodextrin and 1 % magnesium
stearate, was spiked with reference standards to contain total
flavonolignan contents of 1.5, 5.0, and 11.8 %w/w and diluted
to a total volume of 25 mL with methanol, followed by son-
ication for 30 min at 45 °C. Samples were prepared in tripli-
cate on three separate days and subjected to HPLC analysis.
Stability of standards Flavonolignan stability was assessed
by preparing a stock solution containing 100 ppm of each
flavonolignans in methanol and was stored at room tempera-
ture for 72 h. Aliquots of the solution were analyzed in tripli-
cate at the time points 0, 8, 24, 48, and 72 h. Peak areas were
compared to time zero and deviations less than 5 % were
considered acceptable.
Data analysis
Individual flavonolignans from solid samples were quantified
in% (w/w) and liquid samples were quantified inμg/mL using
external calibration.Microsoft Excel was used for calculations
and statistical analyses. Optimization data was evaluated with
Optimization and single-laboratory validation 7661
single-factor analysis of variance (ANOVA) to determine
whether statistically significant differences exist between data
sets. Where appropriate, Tukey’s Honestly Significant Differ-
ence (HSD) post hoc test was used to establish the significance
of results. HorRat values were also calculated using Microsoft
excel. The calculations used to determine the Horwitz ratio
(HorRat), a normalized performance parameter used to evalu-
ate overall method precision, are provided below:
RSDr found;%ð Þ : RSDr ¼ SD Rð Þmean  100
Where SD(r) is the population SD (σ/n, where σ is the sum
of squares and n is the number of replicates).
PRSDr RSDrcalculated;%ð Þ : PRSDr ¼ 2C‐0:15
Where C is the concentration of the analyte expressed as a
mass fraction.





New technologies in column manufacture using core-shell
packing allows for the development of faster and/or higher
resolution separations without requiring new, higher pressure
LC systems. Optimization of the HPLC separation of
silymarins was evaluated using several columns including
Kinetex® 2.6 μm, 3.0×100 mm C8, C18, and XB-C18 core
shell columns, where the XB-C18 column was chosen for
further optimization. Using a mixture of the six flavonolignan
standards, the separation was achieved in less than 25 min
(results not shown). When used to analyze the commercial
products and milk thistle seeds, it was evident that several
minor components were co-eluting with the silychristin,
silydianin, and silybin B peaks. The separation was increased
to 46 min using the milk thistle tincture to optimize the reso-
lution. The chromatograms of the standard mixture, the milk
thistle seeds, and the tincture are shown in Fig. 2. Due to the
complexity of natural products, including milk thistle extracts,
baseline resolution is rarely possible for all major analytes. As
previously observed, there are several minor isomers that co-
elute with silybin B with the same molecular weight and are
not resolved in traditional HPLCmethods [30]. Therefore, this
method improves the separation of these minor components
from the flavonolignans of interest. It was observed that with
MS compatible solvents, silydianin has some peak fronting,
which was improved using the shell core XB-C18 column
compared to other columns [30].
The column used in this separation provided several bene-
fits including a reduction in solvent consumption, increased
resolution of the flavonolignans, and a shorter run time com-
pared to the original INA method [15]. The low back pressure
from this column permits this method to be used by quality
control labs equipped with traditional HPLC systems. This
provides significant cost savings in the separation alone when
this method is incorporated into laboratories.
Optimization studies
Pretreatment Milk thistle seeds can contain as much as 26–
31 % fat, which interferes with flavonolignan extraction [15,
31, 32]. The traditional Soxhlet method involves long extrac-
tion times, high temperatures, large sample sizes, and high
solvent consumption per sample, which are not suitable for
fast routine methods. Pretreatment of milk thistle seeds with
1.5 % H2SO4 is a potential alternative to replace defatting and
has been shown to improve yields in bulk extractions [33].
The dilute acid was thought to break the seed coat cells,
allowing for efficient extraction of the phytochemicals, while
not interfering with the chemical composition of the
flavonolignans [33]. In this work, optimization procedures
for quick, routine analysis were guided using statistical anal-
ysis based on the total silymarin levels.
The pretreatment studies evaluated the silymarin yields after
hexane defatting, treatment with 1.5 %H2SO4, and an untreat-
ed control. These results are summarized in Fig. 3, confirming
that a pretreatment step is necessary prior to the silymarin
extraction. There are significant differences between the three
pretreatment groups (F(2,12)=103, p<0.001). A Tukey’s HSD
post hoc test demonstrated that the hexane pretreatment is
significantly different from the control (non-pretreated) and
acid pretreated samples with a qobs (15.2) and (−3.98)>qcrit
(3.15). As the acid pretreatment uses more environmentally
friendly reagents, less glassware, lab space, and equipment, it
was further optimized. Several pre-treatment solutions were
analyzed for by HPLC, confirming that the flavonolignans
were not extracted during pre-treatment.
In previous work, the exposure time was 24 h for pretreat-
ment [33]. This long pretreatment is not suitable for fast sam-
ple preparation, so the exposure time varied from 0.5 to 24 h.
As summarized in Table 3, there are significant differences
between the 7 pretreatment times (F(6,14)=24.6, p<0.001).
Treatment times (0.5, 1, 2, and 4 h) were found to be signif-
icantly higher than 24 h, given that qobs>qcrit for all. The
flavonolignan levels decreased over time when exposed to
high temperature solvents; therefore, in order to reduce the
exposure of the samples to heat, the 0.5-h pre-treatment time
was selected. No significant differences were observed for
pretreatment or rinse volumes (F(3,8)=1.02, p=0.434). There-
fore, 2 mL was chosen to reduce solvent use.
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Extraction It is necessary to evaluate if sonication used in the
pretreatment optimization is a comparable alternative to the
industry standard Soxhlet extraction. The two extraction
methods were compared using defatted milk thistle seed and
a milk thistle tablet. The silymarin content in the seeds and
tablet were significantly higher using sonication compared
with Soxhlet (F(1,8)=24.6, p <0.01; F(1,8)=12.0, p <0.01), as
shown in Fig. 4. Both materials also resulted in lower variance
using sonication. Therefore, sonication is a suitable alternative
extraction method of the flavonolignans compared to Soxhlet
extraction.When evaluating the individual flavonolignan con-
tents, silydianin levels were lower with Soxhlet extraction.
Silydianin levels decrease significantly when stored as tinc-
tures at room temperature, indicating that it is possibly the
least stable of the six major flavonolignans [34]. Sonication
reduced the degradation of the flavonolignans and improved
the determinations in milk thistle seeds and finished products.
Single-laboratory validation
Selectivity Due to the complex mixtures of components in
milk thistle extracts, resolution of >1.0 was achieved for five
of the major flavonolignans from interfering peaks. Silydianin
contained a small co-eluting component at the front of the
peak, for which resolution could not be improved; therefore,
resolution of less than 1.0 was obtained for this peak in the test
samples. There was no evidence of chromatographic interfer-
ences at 288 nm from other botanical sources in the multicom-
ponent formulations such as schizandra berry, dandelion ex-
tract, or artichoke extract.
Linearity The calibration curves constructed throughout the
optimization and validation studies were linear based on visu-
al inspection. The correlation coefficients were above 0.998,
confirming the linearity of the analytical range for the individ-
ual flavonolignans.
Limits of detection and quantitation Variance checks
showed that the method used was applicable for the analytes.
The MDL and LOQ for each of the flavonolignans are report-
ed in Table 4.
Precision The responses for all of the analytes in the test
materials were above the methods limit of detection. The
silydianin peak was below the limit of quantitation in two
tincture products; therefore, it was reported solely as detected
Fig. 2 HPLC separation and identification of flavonolignans in mixed flavonolignan reference standard (a), milk thistle seeds (b), and milk thistle
























1.5% H2SO4Hexane Defatting No  Pre-treatment
Fig. 3 Comparison of silymarin yield in milk thistle seeds after three
different pre-treatment methods. Asterisk signifies significance (p<0.05)
from the hexane defatting pretreatment condition
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and no precision analysis was performed for silydianin in
these products. The results from three separate days of analy-
sis indicated that all of the analytes had adequate precision in
all of the matrixes evaluated. The HorRat values for the raw
materials ranged from 0.86 to 1.55, dry finished products
ranged from 0.27 to 1.48, and liquid finished products ranged
from 0.21 to 0.98. These values are within the acceptable
range stated by the AOAC SLV guidelines for dietary supple-
ments [26]. The precision data for raw materials and dry fin-
ished products has been summarized in Table 5 and for liquid
finished products in Table 6.
Accuracy qNMR was used to confirm the purities provided
by the suppliers for the flavonolignan standards. Five of the
six standards were found to have residual solvents, with a
purity of greater than 98 % without considering the residual
solvent amounts. The isosilybin B standard was contaminated
with a small organic compound, where twoNMR signals were
observed in the spectrum. It was concluded that the mass
percentage of this component would be low due to the low
molecular weight of the contaminant, although the mole per-
centage of the contaminant was 11 %. Due to the high purities
observed in qNMR for the flavonolignans, the purities provid-
ed by the suppliers, ranging from 94–96 % including residual
solvent levels, were used for quantitation.
The silybin A/B mixed standard was assessed for purity in
comparison to the individual silybin A and silybin B reference
standards. The calculated purity of silybin Awas 47.2 % and
for silybin B it was 50.2 %. The values obtained were slightly
different in comparison with the suppliers’ specifications of
47.0 and 52.6 % respectively, although the total silybin con-
tent is similar (97.4 % calculated versus 97.1 % supplier spec-
ifications). The silybin A/B mixture is a suitable alternative to
be used in place of the individual reference standards silybin A
and B.
The method accuracy was evaluated using a negative con-
trol spike recovery test at three concentration levels for all six
flavonolignans. The spike concentrations ranged from 1.5 to
11.8 % w/w total flavonolignans in order to cover the concen-
trations found in milk thistle seeds and capsules, while the
individual flavonolignan ratios were similar to those found
in milk thistle seeds. The results for recovery are summarized
in Table 7, where the average ranged from 94.6 to 99.9 %.
Stability of standards Throughout the validation, samples
were in queue for hours prior to injection; therefore, a mixture
Table 3 Comparison of total
silymarin content in milk thistle
seeds after pretreatment exposure
times from 0.5 to 24 h with 1.5 %
H2SO4
Pretreatment time (h) Average (%w/w) Standard deviation (%w/w) ANOVA HSD post
hoc test
Variance P value
0.5 2.15 0.06 0.004 <0.001 11.9a
1 2.13 0.09 0.008 11.2a
2 2.05 0.07 0.005 9.01a
4 2.02 0.05 0.002 7.92a
6 1.84 0.05 0.003 2.59
18 1.78 0.02 0.0003 0.90
24 1.75 0.03 0.0008 –


























Fig. 4 Comparison of silymarin content (%w/w) in defatted milk thistle
seeds and in ground milk thistle tablets using two extraction techniques:
Soxhlet and sonication at 45 °C. Asterisk signifies significance (p<0.05)
from the Soxhlet extraction technique
Table 4 Method detection limit (MDL) and limit of quantitation (LOQ)
calculated for each of the flavonolignans
Flavonolignan MDL (μg/mL) LOQ (μg/mL)
Silychristin 0.01 0.27
Silydianin 0.05 0.14
Silybin A 0.03 0.08
Silybin B 0.06 0.15
Isosilybin A 0.02 0.06
Isosilybin B 0.03 0.07
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of flavonolignan standards in methanol was stored at room
temperature for 72 h to confirm flavonolignan stability. Based
on the minimal changes in peak area (<2 %) from the initial
injections, no degradation of the flavonolignans occurred. It is
recommended that stock solutions be stored at −20 °C when
not in use, as no long-term storage analysis was performed at
higher temperatures.
Conclusions
The INA method for flavonolignan quantitation recommend-
ed by the AOAC ERP underwent significant redevelopment
and optimization according to statistically guided optimiza-
tion procedures. The optimized method used a simple and fast
Table 5 Precision results summary for milk thistle raw materials and
dry finished products

































































































































































































Table 6 Precision results summary for milk thistle liquid finished
products









































































Table 7 Negative control spike recovery results for individual









Silychristin 10 90.3 2.96 94.6
35 99.3 2.33
90 94.0 1.57
Silydianin 5 92.5 3.54 95.8
50 97.9 1.95
90 97.0 1.10
Silybin A 10 90.2 1.26 95.6
30 99.2 2.64
90 97.4 2.19










5 101.8 11.85 99.9
10 95.4 8.60
30 102.5 4.97
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sample preparation procedure and was comparable to the orig-
inal method. The method was subjected to a single-laboratory
validation according to AOAC International SLV guidelines
for milk thistle raw materials, bulk extracts, dry finished prod-
ucts, and tinctures. All of the parameters investigated were
found to be within compliance with the guidelines. Therefore,
this method is suitable for determining the concentration of
the 6 main flavonolignans silychristin, silydianin, silybin A,
silybin B, isosilybin A, and isosilybin B in single component
milk thistle preparations or in combination with dandelion,
schizandra berry, and/or artichoke extract. It is recommended
that this method be adopted as Official First Action method
status by AOAC International.
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